CS logo
small CS logo
the second affiliated hospital of Dalian medical university

Dalian, Liaoning, China
Hospital
222 Zhongshan Rd, Xigang District, Dalian, Dalian, Liaoning, 116014

About the second affiliated hospital of Dalian medical university


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Harbin Medical University
4
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
3
Eli Lilly and Company
3
DK Medical Technology (Suzhou) Co., Ltd.
2
Liaoning University of Traditional Chinese Medicine
2
Shanghai Junshi Bioscience Co., Ltd.
2
The First Affiliated Hospital with Nanjing Medical University
2
Beijing InnoCare Pharma Tech Co., Ltd.
1
Betta Pharmaceuticals Co., Ltd.
1
Boehringer Ingelheim
1
Chinese PLA General Hospital
1
Total Rows: 25

Clinical Trials at the second affiliated hospital of Dalian medical university


During the past decade, the second affiliated hospital of Dalian medical university conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 4 clinical trials were completed, i.e. on average, 13.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 3 clinical trials were completed. i.e. 21.4% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2255554422557700000011112200Started TrialsCompleted Trails201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer
2008-12-03
2017-11-13
Completed
1,314
Phase III Study of Compound Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult CML-CP Patients With Ph+
2012-11-01
2018-12-01
Suspended
680
Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain
2013-06-01
2015-12-30
Completed
232
Effectiveness Study of Integrative Treatment for Pediatric Pneumonia
2011-12-01
2013-08-01
Completed
451
Effectiveness Study of Integrative Treatment for Pediatric Community Acquired Pneumonia
2014-04-01
Unknown status
1,500
Application of Monitoring and Intervention Technologies in Suboptimal Health Status
2014-05-01
2015-10-01
Completed
2,014
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer
2016-12-05
2023-09-20
Active, not recruiting
463
Maggot Debridement Therapy Versus Conventional Dressing Therapy to Treat Diabetic Foot Ulcers
2016-06-01
2017-02-01
Unknown status
138

Rows per page:

1–36 of 36

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "the second affiliated hospital of Dalian medical university" #1 sponsor was "Harbin Medical University" with 4 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "DK Medical Technology (Suzhou) Co., Ltd." with 2 trials sponsored and "Liaoning University of Traditional Chinese Medicine" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "the second affiliated hospital of Dalian medical university" #1 collaborator was "Beijing University of Chinese Medicine" with 2 trials as a collaborator, "Core Medical (Beijing) Co., Ltd." with 2 trials as a collaborator, "Sponsor GmbH" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Beijing Anzhen Hospital" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHarbin Medical University: 4Harbin Medical University: 4Chia Tai TianqingPharmaceutical GroupCo., Ltd.: 3Chia Tai TianqingPharmaceutical GroupCo., Ltd.: 3Eli Lilly and Company: 3Eli Lilly and Company: 3DK Medical Technology(Suzhou) Co., Ltd.: 2DK Medical Technology(Suzhou) Co., Ltd.: 2Liaoning University ofTraditional ChineseMedicine: 2Liaoning University ofTraditional ChineseMedicine: 2Shanghai JunshiBioscience Co., Ltd.: 2Shanghai JunshiBioscience Co., Ltd.: 2The First AffiliatedHospital with NanjingMedical University: 2The First AffiliatedHospital with NanjingMedical University: 2Beijing InnoCarePharma Tech Co., Ltd.:1Beijing InnoCarePharma Tech Co., Ltd.:1Betta PharmaceuticalsCo., Ltd.: 1Betta PharmaceuticalsCo., Ltd.: 1Boehringer Ingelheim: 1Boehringer Ingelheim: 1

Created with Highcharts 11.1.0Top CollaboratorsBeijing University ofChinese Medicine: 2Beijing University ofChinese Medicine: 2Core Medical (Beijing)Co., Ltd.: 2Core Medical (Beijing)Co., Ltd.: 2Sponsor GmbH: 2Sponsor GmbH: 2Abbott: 1Abbott: 1Beijing Anzhen Hospital: 1Beijing Anzhen Hospital: 1Beijing Chao Yang Hospital: 1Beijing Chao Yang Hospital: 1Daqing Oil Field Hospital: 1Daqing Oil Field Hospital: 1First Affiliated Hospitalof Guangxi MedicalUniversity: 1First Affiliated Hospitalof Guangxi MedicalUniversity: 1First Affiliated Hospitalof Xinjiang MedicalUniversity: 1First Affiliated Hospitalof Xinjiang MedicalUniversity: 1Peking University FirstHospital: 1Peking University FirstHospital: 1

Clinical Trials Conditions at the second affiliated hospital of Dalian medical university


According to Clinical.Site data, the most researched conditions in "the second affiliated hospital of Dalian medical university" are "Acute Myocardial Infarction" (3 trials), "Breast Cancer" (2 trials), "Carcinoma, Hepatocellular" (2 trials), "Heart Failure" (2 trials) and "Pneumonia" (2 trials). Many other conditions were trialed in "the second affiliated hospital of Dalian medical university" in a lesser frequency.

Clinical Trials Intervention Types at the second affiliated hospital of Dalian medical university


Most popular intervention types in "the second affiliated hospital of Dalian medical university" are "Drug" (23 trials), "Device" (5 trials), "Other" (3 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Fulvestrant" (2 trials), "JS005" (2 trials), "LY2963016" (2 trials) and "Lantus®" (2 trials). Other intervention names were less common.

Clinical Trials Genders at the second affiliated hospital of Dalian medical university


The vast majority of trials in "the second affiliated hospital of Dalian medical university" are 33 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at the second affiliated hospital of Dalian medical university


Currently, there are NaN active trials in "the second affiliated hospital of Dalian medical university". 2 are not yet recruiting, 9 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in the second affiliated hospital of Dalian medical university, 1 suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in the second affiliated hospital of Dalian medical university, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 9 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 12Phase 3: 12Not Applicable: 9Not Applicable: 9Phase 2: 7Phase 2: 7Phase 4: 4Phase 4: 4Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 11Completed: 11Recruiting: 9Recruiting: 9Active, not recruiting: 6Active, not recruiting: 6Unknown status: 6Unknown status: 6Not yet recruiting: 2Not yet recruiting: 2Suspended: 1Suspended: 1Withdrawn: 1Withdrawn: 1